PTC Therapeutics Inc (NASDAQ:PTCT)

55.00
Delayed Data
As of May 06
 +1.87 / +3.52%
Today’s Change
14.51
Today|||52-Week Range
78.72
+6.24%
Year-to-Date

Today’s Trading

Previous close53.13
Today’s open54.13
Day’s range-- - --
Volume1,153,765
Average volume (3 months)736,728
Market cap$1.8B
Dividend yield--
Data as of 05/06/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-54.24%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book5.86

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co-0.14-0.53%
MNKDMannkind Corp-0.01-0.24%
INSYINSYS Therapeutics I...-0.05-0.09%
IRWDIronwood Pharmaceuti...+0.38+2.82%
Data as of 05/06/2015

Financials

Last reporting dateMay 4, 2015
EPS forecast (this quarter)-$1.15
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Executive VP-Research, Operations &
Technology
Neil Gregory Almstead
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers